Top Markets
Coin of the day
Hansa Biopharma AB (publ) Hansa Biopharma AB (publ)

Hansa Biopharma AB (publ)

HNSA
Pozycja w akcjach #13534
Hansa Biopharma AB (publ) is a biopharmaceutical firm dedicated to developing... Hansa Biopharma AB (publ) is a biopharmaceutical firm dedicated to developing immunomodulatory therapies. Leveraging its unique enzyme technology platform, the company targets treatments that facilitate organ transplants and address rare autoimmune conditions driven by immunoglobulin G (IgG), alongside applications in gene therapy and cancer. Its primary drug candidate, Imlifidase, an enzyme therapy designed to cleave antibodies, is currently undergoing Phase 3 clinical trials for use in patients awaiting sensitized kidney transplants and those with anti-GBM antibody disease. Imlifidase is also in Phase 2 trials for treating antibody-mediated kidney transplant rejection and Guillain Barré syndrome. Further pipeline developments include NiceR (Novel immunoglobulin cleaving enzymes for Repeat dosing) for autoimmune diseases, transplantation, and oncology, as well as EnzE (Enzyme based antibody Enhancement) for cancer immunotherapy. Hansa Biopharma also has a preclinical research partnership with argenx BV, exploring the synergistic potential of their respective IgG-modulating technologies. Established in 2007, the company's headquarters are located in Lund, Sweden.
Cena akcji
$4.83
Kapitalizacja rynkowa
$481.23M
Zmiana (1 dzień)
-3.01%
Zmiana (1 rok)
41.08%
Kraj
SE
Handel Hansa Biopharma AB (publ) (HNSA)

Kategoria

Historia ceny akcji dla Hansa Biopharma AB (publ) (HNSA)
Najwyższa cena zamknięcia: $4.66 dnia 2026-08-01

Najniższa cena zamknięcia: $1.23 dnia 2007-10-01
Historia cen akcji firmy Hansa Biopharma AB (publ) od 2007 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 3.21%
2025 18.06%
2024 24.12%
2023 -52.92%
2022 -47.02%
2021 -65.69%
2020 170.40%
2019 -67.23%
2018 9.70%
2017 122.57%
2016 324.99%
2015 -11.09%
2014 181.45%
2013 131.04%
2012 -16.18%
2011 22.26%
2010 -23.87%
2009 62.04%
2008 -57.53%
2007 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$541.44 38.47%
US
$1.03K 43.99%
NL
$121.01 -13.08%
AU
$142.74 492.53%
US
$749.90 5.87%
CH